About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 5827 record(s)
Req # A-2023-001194
All test results relating to the contamination of cantaloupe products, including Malichita or Rudy brand cantaloupes. All emails between Health Canada representatives/employees relating to the contamination of cantaloupe products, including Malichita or Rudy brand cantaloupes. All emails between Health Canada and other government agencies relating to the contamination of cantaloupe products, including Malichita or Rudy brand cantaloupes. All documentation produced and/or received by Health Canada relating to the contamination of cantaloupe products, including Malichita or Rudy brand cantaloupes. From November 1, 2023 to December 18, 2023.Organization: Health Canada
May 2024
Req # A-2023-001233
Review Reports from the Bureau of Pharmaceutical Sciences within the Pharmaceutical Drugs Directorate (PDD) for the Marketed drug SOOTHE RESTORE (Drug Identification Number (DIN) 02465302) from company Bausch & Lomb Inc.Organization: Health Canada
May 2024
Req # A-2023-001339
The number of all on-site audits and inventory investigations undertaken by Health Canada with specific reference to changes in tobacco packaging laws, regulations, practices enforceable by Health Canada; the results of these audits; for the calendar years 2022-2024 with regional breakdowns. The number of all audits and inventory investigations undertaken by Health Canada on First Nations licensed tobacco retailers, wholesalers with specific reference to sales, ingredients and packaging concerns; the results of these audits; for the calendar years 2022-2024 with regional breakdowns. Copies of reports, findings and analyses on the effectiveness of audits and investigations on the achievement of Health Canada tobacco policies or strategies; for the calendar years 2000-2024. Records of all on site audits of manufacturers who reported 0 filings for 2022. Documents detailing the impact of R v Montour on Health Canada tobacco policies or strategies.Organization: Health Canada
May 2024
Req # A-2023-001348
All records related to the licensing of Natural Health Product Natural Product Number (NPN) 80097297 pursuant to the Natural Health Products Regulation under the Food and Drugs Act. All relevant documents in the reporting, licensing request, and approval documents and or records.Organization: Health Canada
May 2024
Req # A-2023-001395
All information in the submission and review of Natural Product Number (NPN) 80087738, brand name: Apple Cider Vinegar.Organization: Health Canada
May 2024
Req # A-2023-001433
All records between the federal government and the province of Albert relating to gender affirming care and puberty blockers for youth from August 10, 2023, to February 10, 2024.Organization: Health Canada
May 2024
Req # A-2023-001480
According to the Health Canada Generic Submissions Under Review (GSUR) List, Health Canada is currently reviewing an Abbreviated Drug Submission (ANDS) seeking approval of a product containing the medicinal ingredient degarelix acetate. If the Degarelix ANDS has received a Screening Acceptance Letter, provide the month and year that the notice was issued; provide a copy of the correspondence.Organization: Health Canada
May 2024
Req # A-2023-001486
Correspondence relating to any Abbreviated New Drug Submission (ANDS) accepted into review as of February 22, 2024 where the medicinal ingredient is degarelix acetate and the correspondence mentions “bio-waiver”.Organization: Health Canada
May 2024
Req # A-2023-001487
Records containing information regarding the evidence of clinical effectiveness of the Degarelix Abbreviated New Drug Submission (ANDS) for the purpose and under the conditions of use recommended, as described in the Food and Drug Regulations.Organization: Health Canada
May 2024
Req # A-2023-001506
From February 28, 2023-February 29, 2024, final versions of all briefing notes / memos/ anticipated media Questions & Answers regarding Kenneth Law and/or Sodium nitrite and it’s use as a suicide substance that were sent to/received by: Minister of Health, Minister of Mental Health, Deputy Minister and Associate Deputy Minister of Health, Assistant Deputy Minister for the Communications and Public Affairs Branch.Organization: Health Canada
May 2024